Common Hormonal Disorder Renamed to Improve Accuracy and Patient Access

A common medical condition affecting millions of women has a new name, as doctors move to make diagnosis and treatment more accessible. The disorder previously known as Polycystic Ovary Syndrome, or PCOS, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome, now referred to as PMOS.

The change, recently introduced in the Lancet Medical Journal, is intended to address long-standing misunderstandings about the condition. Organizations like the Endocrine Society advocate for the new name because it more accurately describes a complex endocrine and metabolic disorder that involves much more than just the ovaries. Experts note that the old name was often misleading for patients and providers alike.

Roughly one in eight women are affected by PMOS. Under the previous name, the focus was primarily on the presence of multiple ovarian cysts. However, many women with the disorder do not have cysts but still experience a wide range of other symptoms. These can include acne, irregular periods, weight gain, excessive hair growth, and the darkening of skin in body creases.

Medical professionals say the focus on cysts often caused significant delays in diagnosis and fragmented care. Some patients were told they did not have the condition simply because an ultrasound did not show cysts, despite exhibiting every other metabolic symptom. The shift to PMOS is expected to reduce this stigma and open the door for more women to seek help for their symptoms.

Treatment for the disorder varies based on the specific symptoms of the individual. By using a broader, more inclusive term, healthcare providers hope to improve access to specialized care and help more women find relief for a condition that is a lifelong health journey rather than just a reproductive issue.

Explore NBCPalmSprings.com, where we are connecting the valley.